Position in ABBV
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$6,919,596
+$865,327 QoQ
Shares Held
27,498
-1.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.96%
of 13F equity value
Holder Rank
#1,119
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Relyea Zuckerberg Hanson LLC holds $22,750,410 across 8 Drug Manufacturers - General names. ABBV ranks #2 (30.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
34,711 | $8,815,552 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
27,498 | $6,919,596 | |
| 3 | LLY |
ELI LILLY & Co
|
3,409 | $4,088,857 | |
| 4 | MRK |
Merck & Co., Inc.
|
10,095 | $1,297,207 | |
| 5 | AMGN |
Amgen Inc
|
1,624 | $588,082 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,176 | $401,255 | |
| 7 | PFE |
Pfizer Inc
|
13,950 | $335,916 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,275 | $303,945 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,919,596 | 27,498 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $6,054,269 | 27,837 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $6,436,106 | 28,168 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $5,706,534 | 24,646 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $4,585,742 | 24,705 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $5,094,269 | 24,314 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $4,280,793 | 24,090 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $2,011,926 | 10,188 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $1,710,225 | 9,971 | Shares | Sole | 2024-10-31 | |
| 2024-03-31 | $1,791,135 | 9,836 | Shares | Sole | 2024-10-31 | |
| 2023-12-31 | $1,441,530 | 9,302 | Shares | Sole | 2024-10-31 | |
| 2023-09-30 | $1,349,589 | 9,054 | Shares | Sole | 2024-10-31 | |
| 2023-06-30 | $1,124,995 | 8,350 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $1,251,851 | 7,855 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $1,112,846 | 6,886 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $797,073 | 5,939 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $869,948 | 5,680 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $913,327 | 5,634 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $778,956 | 5,753 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $559,521 | 5,187 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $568,043 | 5,043 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $532,550 | 4,921 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $505,533 | 4,718 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $414,125 | 4,728 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $468,122 | 4,768 | Shares | Sole | 2020-07-13 | |
| 2020-03-31 | $363,273 | 4,768 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||